Literature DB >> 33960814

The role of imaging in pelvic exenteration for gynecological cancers.

Pamela Ines Causa Andrieu1, Sungmin Woo1, Eric Rios-Doria2, Yukio Sonoda2, Soleen Ghafoor3.   

Abstract

Pelvic exenteration (PE) is one of the most challenging gynecologic oncologic surgeries and is an overriding term for different procedures that entail radical en bloc resection of the female reproductive organs and removal of additional adjacent affected pelvic organs (bladder, rectum, anus, etc.) with concomitant surgical reconstruction to restore bodily functions. Multimodality cross-sectional imaging with MRI, PET/CT, and CT plays an integral part in treatment decision-making, not only for the appropriate patient selection but also for surveillance after surgery. The purpose of this review is to provide a brief background on pelvic exenteration in gynecologic cancers and to familiarize the reader with the critical radiological aspects in the evaluation of patients for this complex procedure. The focus of this review will be on how imaging can aid in treatment planning and guide management.

Entities:  

Mesh:

Year:  2021        PMID: 33960814      PMCID: PMC9327756          DOI: 10.1259/bjr.20201460

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  55 in total

1.  Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.

Authors:  V Andikyan; F Khoury-Collado; Y Sonoda; S R Gerst; K M Alektiar; J S Sandhu; B H Bochner; R R Barakat; P J Boland; D S Chi
Journal:  Gynecol Oncol       Date:  2012-01-28       Impact factor: 5.482

2.  Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations.

Authors:  Nicholas C Lambrou; J Matt Pearson; Hervy E Averette
Journal:  Surg Oncol Clin N Am       Date:  2005-04       Impact factor: 3.495

3.  Complete excision of pelvic viscera for advanced carcinoma; a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy.

Authors:  A BRUNSCHWIG
Journal:  Cancer       Date:  1948-07       Impact factor: 6.860

4.  Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging.

Authors:  S H Kim; M C Han
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

5.  Magnetic resonance imaging/positron emission tomography provides a roadmap for surgical planning and serves as a predictive biomarker in patients with recurrent gynecological cancers undergoing pelvic exenteration.

Authors:  Hebert Alberto Vargas; Irene A Burger; Olivio F Donati; Vaagn Andikyan; Yulia Lakhman; Debra A Goldman; Heiko Schöder; Dennis S Chi; Evis Sala; Hedvig Hricak
Journal:  Int J Gynecol Cancer       Date:  2013-10       Impact factor: 3.437

6.  Validation of MRI and Surgical Decision Making to Predict a Complete Resection in Pelvic Exenteration for Recurrent Rectal Cancer.

Authors:  Wendy E Brown; Cherry E Koh; Tim Badgery-Parker; Michael J Solomon
Journal:  Dis Colon Rectum       Date:  2017-02       Impact factor: 4.585

7.  Overall survival after pelvic exenteration for gynecologic malignancy.

Authors:  Shannon N Westin; Vijayashri Rallapalli; Bryan Fellman; Diana L Urbauer; Navdeep Pal; Michael M Frumovitz; Lois M Ramondetta; Diane C Bodurka; Pedro T Ramirez; Pamela T Soliman
Journal:  Gynecol Oncol       Date:  2014-07-09       Impact factor: 5.482

8.  The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration.

Authors:  Irene A Burger; Hebert Alberto Vargas; Olivio F Donati; Vaagn Andikyan; Evis Sala; Mithat Gonen; Debra A Goldman; Dennis S Chi; Heiko Schöder; Hedvig Hricak
Journal:  Gynecol Oncol       Date:  2013-01-29       Impact factor: 5.482

9.  Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.

Authors:  M Morris; R D Alvarez; W K Kinney; T O Wilson
Journal:  Gynecol Oncol       Date:  1996-02       Impact factor: 5.482

10.  [(18)F]FDG PET/MRI vs. PET/CT for whole-body staging in patients with recurrent malignancies of the female pelvis: initial results.

Authors:  Karsten Beiderwellen; Johannes Grueneisen; Verena Ruhlmann; Paul Buderath; Bahriye Aktas; Philipp Heusch; Oliver Kraff; Michael Forsting; Thomas C Lauenstein; Lale Umutlu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-16       Impact factor: 9.236

View more
  1 in total

1.  BJR female genitourinary oncology special feature: introductory editorial.

Authors:  Stephanie Nougaret; Hebert Alberto Vargas; Evis Sala
Journal:  Br J Radiol       Date:  2021-09-01       Impact factor: 3.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.